Home Diajard-M 12.5mg/500mg for Type 2 Diabetes
Diajard-M 12.5mg 500mg empagliflozin metformin pack
Diajard-M 12.5 500 low-dose metformin IR blister
Diajard-M 12.5mg 500mg empagliflozin metformin pack
Diajard-M 12.5 500 low-dose metformin IR blister

Diajard-M 12.5mg/500mg for Type 2 Diabetes

Diajard-M 12.5mg/500mg Tablet combines empagliflozin 12.5mg (SGLT2 inhibitor) and metformin 500mg immediate release for adults with type 2 diabetes. The lower metformin dose is better tolerated when starting combination therapy or titrating up gradually. A prescription is required for this medication. Do not stop without consulting your doctor. Sick-day rule: temporarily stop during severe illness, dehydration, or when unable to eat — consult your doctor immediately. Risk of euglycaemic diabetic ketoacidosis (DKA): seek emergency care if you experience persistent nausea, vomiting, abdominal pain, or unusual fatigue. May increase risk of genital yeast infections and urinary tract infections. May cause dizziness — sit or stand up slowly. Take with food to reduce stomach upset.

Sale price Rs. 266

Pay in 3 Installments of

Rs.

101

Availability: In stock SKU: DER0000006313
Tags: Blood Sugar Control Medicine Diabetes Management Tablet Diabetes Medicine Derma.pk Diajard-M 12.5mg 500mg Diajard-M Tablets Dual Combination Diabetes Tablet Empagliflozin Metformin Tablet Metformin 500mg Tablet Non Insulin Diabetes Medicine Oral Antidiabetic Drug Prescription Diabetes Tablet SGLT2 Inhibitor Tablet 2 Diabetes Medicine
Diajard-M 12.5mg 500mg empagliflozin metformin pack

Diajard-m 12.5mg/500mg for Type 2 Diabetes

Rs. 266

Diajard-M Tablets 12.5mg/500mg – Dual Action Blood Sugar Management

Diajard-M Tablets 12.5mg/500mg are a prescription oral antidiabetic medication used for the management of type 2 diabetes mellitus in adults. This effective combination therapy contains empagliflozin and metformin, working together to provide reliable blood sugar control when diet and lifestyle modifications alone are not sufficient.

Empagliflozin lowers blood glucose levels by increasing glucose excretion through the kidneys, while metformin reduces glucose production in the liver and improves the body’s response to insulin. This complementary mechanism helps control both fasting and post-meal blood sugar levels without causing excessive insulin release.

Diajard-M 12.5mg/500mg is especially suitable for patients who need combination therapy but at a moderate metformin dose. When used consistently alongside a healthy diet and regular physical activity, it supports long-term diabetes management and helps reduce the risk of diabetes-related complications.

This medication should be taken strictly as prescribed by a healthcare professional. Regular blood glucose monitoring is recommended to ensure effective and safe treatment.

How to Order Diajard-M 12.5mg/500mg  at Derma.pk

At Derma.pk, we ensure the authenticity of Diajard-M Tablets 12.5mg/500mg, verified by licensed pharmacists. Delivery is available across Pakistan. For prescriptions or inquiries, contact sales@derma.pk or WhatsApp +92-320-5999650.

Usage & Benefits

Lower 500mg metformin dose reduces gastrointestinal side effects when starting combination therapy
Empagliflozin lowers blood sugar via urinary glucose excretion with cardio-renal benefits
Low intrinsic hypoglycaemia risk — neither component forces insulin release
Two essential diabetes mechanisms in one convenient tablet
Allows gradual metformin titration while benefiting from SGLT2 inhibition from day one
Suitable for patients who are sensitive to higher metformin doses

How To Use

Take one Diajard-M 12.5mg/500mg tablet twice daily with meals. Take with food to reduce stomach upset. Swallow whole with water — do not crush or chew. Do not stop without consulting your doctor. Sick-day rule: temporarily stop during severe illness, vomiting, diarrhoea, dehydration, before contrast imaging, or before surgery — consult your doctor immediately. Risk of euglycaemic diabetic ketoacidosis (DKA): seek emergency care if you experience persistent nausea, vomiting, abdominal pain, or unusual fatigue — even when blood sugar appears normal. May increase risk of genital yeast infections and urinary tract infections. May cause dizziness — sit or stand up slowly. Avoid heavy alcohol. Monitor eGFR and vitamin B12 periodically as directed.

FAQs

Why is 500mg metformin used in this tablet instead of 1000mg?

The lower 500mg metformin dose is better tolerated, especially when starting combination therapy. It reduces nausea, bloating, and diarrhoea while still providing meaningful blood sugar lowering. Your doctor may increase the strength over time.

What are the sick-day rules for this combination?

Temporarily stop Diajard-M 12.5/500 during vomiting, diarrhoea, fever, dehydration, fasting, before contrast-dye imaging, or before surgery. Both DKA and lactic acidosis risks increase — consult your doctor immediately.

What is lactic acidosis?

Lactic acidosis is a rare but serious side effect of metformin, more likely with dehydration, severe infection, kidney impairment, or heavy alcohol use. Seek urgent care for unusual fatigue, muscle pain, breathlessness, or vomiting.

What DKA symptoms should I watch for?

Seek emergency care if you have persistent nausea, vomiting, abdominal pain, or unusual fatigue — even when blood sugar reads normal. This euglycaemic DKA risk comes from the SGLT2 inhibitor component.

What is the kidney function cut-off for this medication?

Diajard-M 12.5/500 is contraindicated below eGFR 45 mL/min. Your doctor will monitor kidney function regularly during treatment.